AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 123 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -60.0% | 28,500 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $5,000 | -61.5% | 28,500 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $13,000 | -56.7% | 28,500 | -46.7% | 0.00% | -50.0% |
| Q4 2021 | $30,000 | -66.3% | 53,500 | 0.0% | 0.01% | -61.9% |
| Q3 2021 | $89,000 | -21.9% | 53,500 | -21.9% | 0.02% | -19.2% |
| Q2 2021 | $114,000 | -1.7% | 68,500 | 0.0% | 0.03% | -7.1% |
| Q1 2021 | $116,000 | +6.4% | 68,500 | 0.0% | 0.03% | -3.4% |
| Q4 2020 | $109,000 | +354.2% | 68,500 | +168.6% | 0.03% | +314.3% |
| Q3 2020 | $24,000 | +50.0% | 25,500 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $16,000 | +6.7% | 25,500 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $15,000 | +15.4% | 25,500 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $13,000 | +30.0% | 25,500 | 0.0% | 0.00% | +33.3% |
| Q2 2019 | $10,000 | -47.4% | 25,500 | -23.9% | 0.00% | -40.0% |
| Q1 2019 | $19,000 | +26.7% | 33,500 | -10.7% | 0.01% | -16.7% |
| Q4 2018 | $15,000 | -86.4% | 37,500 | -25.0% | 0.01% | -85.7% |
| Q2 2018 | $110,000 | -35.3% | 50,000 | 0.0% | 0.04% | -37.3% |
| Q1 2018 | $170,000 | – | 50,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |